REPRESENTATIONS AND WARRANTIES OF SIGNATURE Sample Clauses

REPRESENTATIONS AND WARRANTIES OF SIGNATURE. 4- 2.01. Organization; Good Standing; Power, Etc.......................................................-4- 2.02. Authorization of Agreement, Etc...............................................................-4- 2.03. Capitalization................................................................................-7- 2.04. Absence of Certain Changes or Events..........................................................-8- 2.05. Signature SEC Reports.........................................................................-9- 2.06. Defaults.....................................................................................-10- 2.07. Tax Matters..................................................................................-10- 2.08. Trademarks, Copyrights, Etc..................................................................-11- 2.09. Title to Properties: Absence of Liens and Encumbrances: Leases, etc..........................-12- 2.10.
AutoNDA by SimpleDocs
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. 2.1 ORGANIZATION.......................................................... 4 2.2 ARTICLES OF INCORPORATION, BYLAWS AND AGREEMENTS...................... 4 2.3 AUTHORIZATION......................................................... 4 2.4
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. Signature represents and warrants to PRG and the PRG Shareholders as follows:
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. Signature hereby represents and warrants to Xxxxxxx as follows:
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. Signature hereby represents and warrants to Jamexxx xx follows:
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. Section 6.01. Organization, Authority and Capacity 7 Section 6.02. Authorization and Validity 7 Section 6.03. Absence of Conflicting Agreements or Required Consents 7 Section 6.04. Governing Documents of Signature 7 Section 6.05. Outstanding and Authorized Capitalization 8 Section 6.06. Financial Statements 8 Section 6.07. Absence of Changes 6 Section 6.08. No Undisclosed Liabilities 9 Section 6.09. Litigation, Etc 9 Section 6.10. Real and Personal Property 9 Section 6.11. Insurance Policies 9 Section 6.12. Taxes 10 Section 6.13. Required Vote of Signature Shareholders 10 Section 6.14. Statements True and Correct 10
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. SIGNATURE represents and warrants the following to LUMMI, as of the date of this Agreement and as of the Closing and the Effective Time:
AutoNDA by SimpleDocs
REPRESENTATIONS AND WARRANTIES OF SIGNATURE. 15.1. Signature represents and warrants to the GGCRL Shareholders that unless required or contemplated by this Agreement, without the prior written consent of the GGCRL Shareholders, it will not prior to the Completion Date: a) Incur or enter into any Material Commitment; b) Allot or issue or agree to allot or issue any share or loan capital or any security or option convertible or exercisable into any share or loan capital or agree to do any such thing; c) Declare or pay any dividend or make any other distribution of its assets or profits or agree to do any such thing; d) Alter or agree to alter its constitution; or e) Pass any ordinary or special resolution other than in respect of ordinary business at the Meeting and agrees to comply with its future ASX and Corporate compliance obligations by holding such Meeting with proper accounts. 15.2. Signature represents and warrants to the GGCRL Shareholders that it has not agreed to do any of the things referred to in clause 15.1 which remains to be completed or done after the date of this Agreement and there are no (and at Completion there will) not be any other extant claims against Signature save those arising under a Transaction and then within the contemplation of this Agreement. 15.3. Signature represents and warrants to the GGCRL Shareholders that it has made full, true, and plain disclosure of all material facts which: (a) Would or might affect the decision of the GGCRL Shareholders or either of them to complete the Transaction; (b) Is material to be known by a potential purchaser for the value of shares in Signature; (c) Could reasonably be expected to be relevant to the decision of a potential purchaser of the shares in Signature to purchase shares in Signature or to the terms of such purchase. 15.4. The representations and warranties in clauses 15.1 to 15.3 are deemed to be repeated by Signature immediately prior to Completion. 15.5. Signature must give notice to the GGCRL Shareholders of the occurrence of any event prior to the Completion Date that would render any of the representations or warranties in either of clauses 15.1 and 15.2 inaccurate at the time given or to be repeated at Completion.

Related to REPRESENTATIONS AND WARRANTIES OF SIGNATURE

  • REPRESENTATIONS AND WARRANTIES OF SPAC SPAC hereby represents and warrants to each Company Shareholder and the Company during the Exclusivity Period as follows:

  • Representations and Warranties of XXXX XXXX hereby represents and warrants to the Seller and the Servicer as of the Initial Closing Date and each Subsequent Closing Date:

  • REPRESENTATIONS AND WARRANTIES OF XXXXXX Xxxxxx hereby represents and warrants to the Xxxxxx Group that (a) Xxxxxx has the power and authority to enter into this Agreement and the Xxxxxx Assignment and to carry out his obligations hereunder and thereunder, (b) the execution and delivery of this Agreement and the Xxxxxx Assignment by Xxxxxx has been duly authorized by all necessary action on the part of Xxxxxx and no other proceedings on the part of Xxxxxx are necessary to authorize this Agreement or the Xxxxxx Assignment, (c) this Agreement has been duly executed and delivered by Xxxxxx and constitutes a valid and binding obligation of Xxxxxx, and, assuming this Agreement constitutes a valid and binding obligation of the Xxxxxx Group, is enforceable against Xxxxxx in accordance with its terms (subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws affecting creditors’ rights generally and general principles of equity), (d) the Xxxxxx Assignment has been duly executed and delivered by Xxxxxx and constitutes a valid and binding obligation of Xxxxxx, and, assuming the Xxxxxx Assignment constitutes a valid and binding obligation of Splitco, is enforceable against Xxxxxx in accordance with its terms (subject to applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws affecting creditors’ rights generally and general principles of equity), (e) neither the execution, delivery or performance of this Agreement or the Xxxxxx Assignment by Xxxxxx constitutes a breach or violation of, or conflicts with any provision of any material agreement to which Xxxxxx is a party, and (f) none of such material agreements would impair in any material respect the ability of Xxxxxx to perform his obligations hereunder or thereunder.

  • Representations and Warranties of Xxxxx Xxxxx represents and warrants to Spruce that, as of the Effective Date: (a) it has the full right, power and authority to enter into this Agreement, to grant the rights and licenses granted under Articles 2 and 3, and its execution of this Agreement, the fulfillment of its obligations and performance of its activities hereunder do not conflict with, violate, or breach or constitute a default under any material contractual obligation or court or administrative order by which Lilly is bound; (b) to the knowledge of Lilly, there are no legal claims, judgments or settlements against or owed by Lilly or any of its Affiliates, threatened or pending legal claims or litigation, in each case relating to the Licensed Patents; (c) all necessary consents, approvals and authorizations of all government authorities and other persons required to be obtained by Lilly as of the Effective Date in connection with the execution, delivery and performance of this Agreement have been obtained; (d) it is the owner or exclusive licensee of or otherwise Controls the right, title and interest in and to the Licensed Patents and related Licensed Know-How, and has the right to grant to Spruce the licenses that it purports to grant hereunder and has not granted any Third Party rights that would interfere or be inconsistent with Spruce’s rights hereunder; (e) the Licensed Patents and Licensed Know-How are not subject to any existing royalty or other payment obligations to any Third Party; (f) it has disclosed to Spruce a complete and accurate record of all material information and data relating to the results of all pre-clinical and clinical studies on Licensed Products or the Licensed Compound, conducted by or on behalf of Lilly or any of its Affiliates or otherwise known to Lilly, including, without limitation, the status and interim results of all ongoing clinical and preclinical studies, and the clinical development and Regulatory Application and Regulatory Approval activities undertaken to date, and all such information and data is complete and accurate in all material respects; (g) neither it nor any of its Affiliates has been debarred or is subject to debarment; (h) it has the authority to bind its Affiliates to the terms of this Agreement, as applicable, and to grant the rights and licenses granted on behalf of its Affiliates as set forth herein; (i) all documents required to be filed and all payments required to be made in order to prosecute and maintain each Patent in the Licensed Patents have been filed or made, as the case may be, in a timely manner, and no action has been taken that would constitute waiver, abandonment or any similar relinquishment of such rights; (j) the Licensed Patents constitute all Patents owned by or licensed to Lilly or any of its Affiliates that contain one or more claims covering any Licensed Product or Licensed Compound, or the composition of matter, method of use or manufacture thereof; (k) neither Lilly nor any of its Affiliates is or has been a party to any agreement with any U.S. Governmental Authority pursuant to which any U.S. Governmental Authority provided funding for the Development of any Licensed Compound or any Licensed Product, and the inventions claimed or covered by the Existing Patents are not a “subject invention” as that term is described in 35 U.S.C. Section 201(f); and (l) neither Lilly nor any of its Affiliates, nor any of its or their respective officers, employees, or agents has made an untrue statement of material fact or fraudulent statement to the FDA or any other Regulatory Authority with respect to the Development of any Licensed Compound or Licensed Product, failed to disclose a material fact required to be disclosed to the FDA or any other Regulatory Authority with respect to the Development of any Licensed Compound or any Licensed Product, or committed an act, made a statement, or failed to make a statement with respect to the Development of any Licensed Compound or Licensed Product that could reasonably be expected to provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities”, set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto or any analogous laws or policies in any other country.

  • Representations and Warranties of Vendor Vendor represents and warrants that the following shall be true and correct as of the effective date of this Agreement and shall continue to be true and correct during the Term of this Agreement:

  • REPRESENTATIONS AND WARRANTIES OF XXXXXXX Xxxxxxx hereby represents and warrants to the Company as follows:

  • Representations and Warranties of Both Parties On the Execution Date, each Party represents and warrants to the other Party that: It is duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation; Except for CPUC Approval in the case of Buyer, it has or will timely acquire all regulatory authorizations necessary for it to legally perform its obligations under this Agreement; The execution, delivery and performance of this Agreement are within its powers, have been duly authorized by all necessary action and do not violate any of the terms and conditions in its governing documents, any contracts to which it is a party or any law, rule, regulation, order or the like applicable to it; This Agreement constitutes its legally valid and binding obligation, enforceable against it in accordance with its terms; It is not Bankrupt and there are no proceedings pending or being contemplated by it or, to its knowledge, threatened against it which would result in it being or become Bankrupt; There is not pending or, to its knowledge, threatened against it, any legal proceedings that could materially adversely affect its ability to perform its obligations under this Agreement; It (i) is acting for its own account, (ii) has made its own independent decision to enter into this Agreement and as to whether this Agreement is appropriate or proper for it based upon its own judgment, (iii) is not relying upon the advice or recommendations of the other Party in so doing, and (iv) is capable of assessing the merits of and understanding, and understands and accepts, the terms, conditions, and risks of this Agreement; and It has entered into this Agreement in connection with the conduct of its business and it has the capability or ability to make available or take delivery of, as applicable, the Product under this Agreement in accordance with the terms of this Agreement.

  • Representations and Warranties of ALPS ALPS represents and warrants to the Trust that: (a) It is duly organized and existing as a corporation and in good standing under the laws of the State of Colorado. (b) It is empowered under applicable laws and by its Articles of Incorporation and By-laws to enter into and perform this Agreement. (c) All requisite corporate proceedings have been taken to authorize it to enter into and perform this Agreement. (d) It has and will continue to have access to the necessary facilities, equipment and personnel to perform its duties and obligations under this Agreement in accordance with industry standards.

  • Representations and Warranties of Sponsor The Sponsor represents and warrants to, and agrees with, the Investor that:

  • Representations and Warranties of Parties A. Redeveloper represents and warrants to City as follows:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!